Immuron (IMRN) Enterprise Value (2016 - 2025)
Immuron's (IMRN) quarterly Enterprise Value came in at -$11.7 million in Q3 2025, up 32.07% year-on-year from -$8.8 million in Q3 2024, and down 543.07% quarter-over-quarter from -$1.8 million in Q2 2025.
Immuron (IMRN) Enterprise Value (2016 - 2025) Analysis & Trends
Immuron's Enterprise Value history runs 10 years deep, the most recent figure standing at -$11.7 million for Q3 2025.
- On a quarterly basis, Enterprise Value rose 32.07% year-over-year to -$11.7 million in Q3 2025; TTM through Sep 2025 was -$11.7 million, a 32.07% increase from a year earlier, with the FY2025 full-year figure at -$11.7 million, up 32.07% from the prior year.
- Enterprise Value eased to -$11.7 million in Q3 2025 per IMRN's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$171597.6 in Q3 2023 and bottomed at -$19.3 million in Q2 2021.
- The 5-year median for Enterprise Value is -$11.5 million (2023), against an average of -$11.3 million.
- Across the five-year window, Enterprise Value soared 98.88% in 2023 and plunged 9900.0% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$18.3 million in 2021, then rose by 20.77% to -$14.5 million in 2022, then advanced by 23.1% to -$11.2 million in 2023, then soared by 31.76% to -$7.6 million in 2024, then slumped by 52.92% to -$11.7 million in 2025.
- Per Business Quant, the three latest IMRN Enterprise Value figures stand at -$11.7 million (Q3 2025), -$1.8 million (Q2 2025), and -$7.6 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | -28.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | -28.31 Bn |
| Jun 30, 2025 | -2.00 Mn |
| Dec 31, 2024 | -8.23 Mn |
| Sep 9, 2024 | -116,573.15 |
| Jun 30, 2024 | -8.23 Mn |
| Dec 31, 2023 | -13.32 Mn |
| Sep 28, 2023 | -12.12 Mn |
| Aug 30, 2023 | -171,597.64 |
| Jun 30, 2023 | -13.41 Mn |
| Dec 31, 2022 | -15.61 Mn |
| Aug 31, 2022 | -15.61 Mn |
| Jun 30, 2022 | -15.61 Mn |
| Dec 31, 2021 | -17.69 Mn |
| Jun 30, 2021 | -2.74 Mn |
| Dec 31, 2020 | -264,447.68 |
| Sep 1, 2020 | -5.12 Mn |
| Jun 30, 2020 | -2.30 Mn |
| Dec 31, 2019 | -5.12 Mn |
| Jun 30, 2019 | -5.12 Mn |
| Dec 31, 2018 | -4.73 Mn |